Drug Abuse News and Research

RSS

Millennium Labs founder receives Ernst & Young award in Life Sciences category

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, has received the Ernst & Young Entrepreneur of the Year 2011 San Diego Award in the Life Sciences category.

21 Jun 2011

University of Helsinki psychiatric professor to receive Nordic Public Health Prize 2011

The Nordic Public Health Prize 2011 will be awarded to Professor of Psychiatry Jouko Lönnqvist for his internationally acclaimed research on the causes, spread and prevention of mental illness at population- and individual level.

21 Jun 2011

Drug addiction management costs UK £3.6bn a year: Report

According to a latest report from the think tank the Centre for Policy Studies (CPS), drug addiction costs £3.6bn a year for both treating problem drug users and keeping them on benefits. The study by has criticised government plans to change the way authorities tackle drug addiction. It claims the plans for payment-by-results schemes are “doomed to failure, not least because they are being run by the very organizations responsible for the current failure of policy”.

19 Jun 2011

Study shows increase in emergency department visits for drug-related suicide attempts among men

A new national study shows that from 2005 to 2009 there was a 55 percent increase in emergency department visits for drug related suicide attempts by men aged 21 to 34 -- from 19,024 visits in 2005 to 29,407 visits in 2009. In 2009, there were a total of 77,971 emergency department visits for drug-related suicide attempts among males of all ages.

18 Jun 2011

Alkermes commences ALKS 5461 phase 1/2 study for treatment-resistant depression

Alkermes, Inc. today announced the initiation of a phase 1/2 study of ALKS 5461 for treatment-resistant depression (TRD). ALKS 5461 is the combination of ALKS 33, a proprietary opioid modulator, and buprenorphine. TRD, which is also known as refractory depression, refers to depressive episodes that are not adequately controlled by standard antidepressant therapy.

15 Jun 2011

Scientists zero in on dose levels of "sacred mushroom"

Scientists at the Johns Hopkins University School of Medicine have zeroed in on the dose levels of the "sacred mushroom" chemical capable of yielding positive, life-changing experiences, while minimizing the chance of transient negative reactions in screened volunteers under supportive, carefully monitored conditions.

15 Jun 2011

Texas employers can learn about signs, symptoms of drug impairment at SHSU inaugural program

Texas employers can learn about the signs and symptoms of drug impairment among workers at an inaugural program being held at Sam Houston State University (SHSU) June 14. The free, six-hour program will be available to all Texas employers after Sept. 1, 2011.

14 Jun 2011

Scripps Research receives $2.2M NIH grant to develop novel therapeutics for substance abuse

The Scripps Research Institute has been awarded a $2.2 million grant from the National Institutes of Health (NIH) to develop novel therapeutics for the treatment of addiction to multiple substances in a national effort with the University of Kansas.

10 Jun 2011

Leadership Reads Initiative to minimize teen alcohol consumption and drug use

The incidence of alcohol poisoning, alcohol-related violence, and alcohol-impaired driving is increasing at an alarming rate among teens. If teens start to drink early, they are six times more likely to develop alcohol dependence.

9 Jun 2011

Ameritox launches Rx Guardian CD, next-generation pain-medication monitoring solution

Ameritox, the leader in pain-medication monitoring, today announced the launch of Rx Guardian CD, its next-generation pain-medication monitoring solution and part of the patented Rx Guardian process.

9 Jun 2011

Celebrities urge decriminalization of drug possession

Dame Judi Dench, Sir Richard Branson, actress Julie Christies and Sting have added their support to an ex-drugs minister and three former chief constables in calling for the decriminalization of the possession of all drugs. These celebrities together with leading lawyers, academics, artists and politicians have signed an open letter to David Cameron to mark this week's 40th anniversary of the 1971 Misuse of Drugs Act. The letter, published in a full-page advertisement in Thursday's Guardian, calls for a “swift and transparent” review of the effectiveness of current drugs policies.

2 Jun 2011

Transcendental Meditation reduces symptoms of PTSD in veterans just within 8 weeks

Veterans of the Iraq/Afghanistan wars showed a 50 percent reduction in their symptoms of post-traumatic stress disorder (PTSD) after just eight weeks of practicing the stress-reducing Transcendental Meditation technique, according to a pilot study published in the June 2011 issue of Military Medicine.

2 Jun 2011

Report: Only 2% of nation's substance abuse treatment facilities offer counseling services in Asian languages

A new report shows that only 2-percent (291) of the nation's 13,513 substance abuse treatment facilities provide counseling services in various Asian languages. The report also showed that the proportion of facilities offering these services varied by geographic region.

27 May 2011

Research provides new understanding of how heroin affects the brain

New research from the Norwegian Institute of Public Health suggests that our understanding of how heroin affects the brain should be changed. A new report shows that heroin is metabolised to 6-MAM which then crosses the blood-brain barrier to cause the intoxicating effects that arise shortly after heroin administration.

27 May 2011

'Survival protein' protects brain against effects of stroke

Johns Hopkins scientists say that a newly discovered "survival protein" protects the brain against the effects of stroke in rodent brain tissue by interfering with a particular kind of cell death that's also implicated in complications from diabetes and heart attack.

24 May 2011

Discovery of possible new strategy for treating neurologic disorders

23 May 2011

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, is a regional finalist for the Ernst & Young Entrepreneur of the Year 2011 San Diego region.

23 May 2011

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society, www.ampainsoc.org, today honored the recipients of its fifth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

21 May 2011

'Mu opioid' receptors in the brain linked to smoking relapse

Nearly everyone who has tried to quit smoking says it's incredibly difficult, and the struggle is due in part to genetic factors. Now, a new study from the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania sheds light on how one specific genetic risk for smoking relapse may work: Some of the difficulties may be due to how many receptors, called "mu opioid" receptors, a smoker has in his or her brain.

17 May 2011

Early antiretroviral treatment can halt HIV spread in couples

A research study led by the University of North Carolina at Chapel Hill has made a major discovery in the effort to halt the spread of HIV, the virus that causes AIDS.

13 May 2011